When did ABBV join the S&P 500?

AbbVie joined the S&P 500 index on 2013-01-02.

What sector is ABBV in?

ABBV is in the Health Care sector, Biotechnology industry.

ABBV — AbbVie

Name: ABBV Institutional Holdings (13F) — 2026Q1
Creator: SEC EDGAR
License: https://www.sec.gov/data

Biotechnology · Health Care

Key Facts

Status	Active
Sector	Health Care
Industry	Biotechnology
Joined	2013-01-02
Tenure	13 yrs

AbbVie is a research-based biopharmaceutical company engaged in the development and sale of pharmaceutical products. Its focus areas include chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology (including hematologic malignancies); virology, encompassing Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV); neurological disorders (such as Parkinson's disease); metabolic diseases (including thyroid disorders and complications associated with cystic fibrosis); pain associated with endometriosis; and other serious health conditions.

Industry Peers

AMGN BIIB GILD INCY MRNA REGN VRTX

Sector Peers

A ABT ALGN AMGN BAX BDX BIIB BMY BSX CAH

S&P 500 Timeline

2013-01-02Joined S&P 500

Institutional Holdings (13F)

4,069 institutions hold ABBV, totaling 1.72B shares ($353.4B) · As of 2026Q1

Rank	Institution	Shares	Value
1	VANGUARD CAPITAL MANAGEMENT LLC	229.8M	$50.0B
2	BlackRock, Inc.	150.7M	$32.8B
3	MORGAN STANLEY	119.7M	$27.1B
4	STATE STREET CORP	81.2M	$17.7B
5	DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	93.6M	$13.0B
6	JPMORGAN CHASE & CO	56.7M	$12.1B
7	VANGUARD PORTFOLIO MANAGEMENT LLC	49.5M	$10.8B
8	GEODE CAPITAL MANAGEMENT, LLC	46.7M	$10.1B
9	BARCLAYS PLC	53.3M	$9.9B
10	Capital Research Global Investors	31.3M	$6.8B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10